Related references
Note: Only part of the references are listed.Inhibition of angiotensin II receptor 1 limits tumor-associated angiogenesis and attenuates growth of murine melanoma
Andreia Hanada Otake et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2010)
Aspirin Intake and Survival After Breast Cancer
Michelle D. Holmes et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
New Studies Support Case for Bisphosphonates as Possible Chemopreventive Agent
Charlie Schmidt
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Blockade of an angiotensin type I receptor enhances effects of radiation on tumor growth and tumor-associated angiogenesis by reducing vascular endothelial growth factor expression
Yuichiro Ohnuma et al.
BIOMEDICINE & PHARMACOTHERAPY (2009)
Melanoma incidence and exposure to angiotensin-converting enzyme inhibitors and angiotensin receptor blockers
E. R. Koomen et al.
CANCER EPIDEMIOLOGY (2009)
Reduced Risk of Bone Metastasis for Patients With Breast Cancer Who Use COX-2 Inhibitors
Matias E. Valsecchi et al.
CLINICAL BREAST CANCER (2009)
Impact of angiotensin I converting enzyme inhibitors and angiotensin II type 1 receptor blockers on survival in patients with advanced non-small-cell lung cancer undergoing first-line platinum-based chemotherapy
Stefan Wilop et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2009)
Angiotensin inhibition and malignancies: a review
T. Rosenthal et al.
JOURNAL OF HUMAN HYPERTENSION (2009)
Endocrine Therapy plus Zoledronic Acid in Premenopausal Breast Cancer
Michael Gnant et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
AGTR1 overexpression defines a subset of breast cancer and confers sensitivity to losartan, an AGTR1 antagonist
Daniel R. Rhodes et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Estrogen receptor-negative breast cancer is less likely to arise among lipophilic statin users
Anjali S. Kumar et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2008)
Antihypertensive medication and their impact on cancer incidence: a mixed treatment comparison meta-analysis of randomized controlled trials
Craig I. Coleman et al.
JOURNAL OF HYPERTENSION (2008)
Association of ACE inhibitors and angiotensin receptor blockers with keratinocyte cancer prevention in the randomized VATTC trial
Jennifer B. Christian et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Simvastatin induces apoptosis in human breast cancer cells in a NF kappa B-dependent manner and abolishes the anti-apoptotic signaling of TF/FVIIa and TF/FVIIa/FXa
Mikael Aberg et al.
THROMBOSIS RESEARCH (2008)
Post-diagnosis statin use and breast cancer recurrence in a prospective cohort study of early stage breast cancer survivors
Marilyn L. Kwan et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Statin-induced breast cancer cell death: Role of inducible nitric oxide and arginase-dependent pathways
Srigiridhar Kotamraju et al.
CANCER RESEARCH (2007)
Insertion/Deletion polymorphism of the angiotensin I-converting enzyme gene in patients with breast cancer and effects on prognostic factors
Arzu Yaren et al.
JOURNAL OF INVESTIGATIVE MEDICINE (2007)
Simvastatin induces apoptosis in human breast cancer cells: p53 and estrogen receptor independent pathway requiring signalling through JNK
Meral Koyuturk et al.
CANCER LETTERS (2007)
Statin use and breast cancer risk in a large population-based setting
Denise M. Boudreau et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
Statins and the risk of lung, breast, and colorectal cancer in the elderly
Soko Setoguchi et al.
CIRCULATION (2007)
Cancer statistics, 2007
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2007)
Statin use and breast cancer: Prospective results from the Women's Health Initiative
JA Cauley et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Reduction in the risk of human breast cancer by selective cyclooxygenase-2 (COX-2) inhibitors
RE Harris et al.
BMC CANCER (2006)
Use of statins and breast cancer: A meta-analysis of seven randomized clinical trials and nine observational studies
S Bonovas et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Serum lipids, lipid-lowering drugs, and the risk of breast cancer
AH Eliassen et al.
ARCHIVES OF INTERNAL MEDICINE (2005)
Angiotensin-converting enzyme gene insertion/deletion polymorphism and breast cancer risk
AMGZ Ladd et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2005)
Functional expression of the angiotensin II type 1 receptor in human ovarian carcinoma cells and its blockade therapy resulting in suppression of tumor invasion, angiogenesis, and peritoneal dissemination
T Suganuma et al.
CLINICAL CANCER RESEARCH (2005)
Polymorphisms in angiotensin II type 1 receptor and angiotensin I-converting enzyme genes and breast cancer risk among Chinese women in Singapore
WP Koh et al.
CARCINOGENESIS (2005)
Angiotensin type 1a receptor signaling-dependent induction of vascular endothelial growth factor in stroma is relevant to tumor-associated angiogenesis and tumor growth
M Fujita et al.
CARCINOGENESIS (2005)
Statin use and cancer risk in the General Practice Research Database
JA Kaye et al.
BRITISH JOURNAL OF CANCER (2004)
The risk of cancer in users of statins
MR Graaf et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
The association between 3-hydroxy-3-methylglutaryl conenzyme A inhibitor use and breast carcinoma risk among postmenopausal women - A case-control study
DM Boudreau et al.
CANCER (2004)
Effects of statins and farnesyltransferase inhibitors on the development and progression of cancer
MR Graaf et al.
CANCER TREATMENT REVIEWS (2004)
Statin use and the risk of breast cancer
P Beck et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2003)
Revision of the American Joint Committee on Cancer staging system for breast cancer
SE Singletary et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Angiotensin II angiogenic effect in vivo involves vascular endothelial growth factor- and inflammation-related pathways
R Tamarat et al.
LABORATORY INVESTIGATION (2002)
Cerivastatin, an inhibitor of HMG-CoA reductase, inhibits the signaling pathways involved in the invasiveness and metastatic properties of highly invasive breast cancer cell lines:: an in vitro study
C Denoyelle et al.
CARCINOGENESIS (2001)
Direct vascular effects of HMG-CoA reductase inhibitors
U Laufs et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2000)
Angiotensin-converting enzyme inhibitors, calcium channel blockers, and breast cancer
CR Meier et al.
ARCHIVES OF INTERNAL MEDICINE (2000)
Share Paper
